✦ LIBER ✦

Oxaliplatin and Fixed-Rate Infusional Gemcitabine in the Second-Line Treatment of Patients with Metastatic Colon Cancer: Final Results of a Phase II Trial Prematurely Closed as a Result of Poor Accrual

✍ Scribed by Gilberto Lopes; Jose Quesada; Eugene Ahn; Aurea Flores; Afonso Ribeiro; Caio Max Rocha-Lima

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

470 Final results of a phase II study of

✍ S. Glück; C. Lobo; G. Lopes; A. Castrellon; J. Hurley; I. Reis; S. Richman; O. S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Docetaxel/gemcitabine or cisplatin/gemci

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

P-457 Docetaxel/gemcitabine vs. cisplati

✍ Binder, D.; Schweisfurth, H.; Grah, C.; Schäper, C.; Temmesfeld-Wollbrück, B.; S 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 276 KB

649 POSTER Erlotinib as single agent in

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

6091 POSTER Final Results of a Multicent

✍ Samalin, E.; Bouche, O.; Thezenas, S.; Frangois, E.; Adenis, A.; Bennouna, J.; T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Carboplatin plus gemcitabine as first-li

✍ Vamvakas, L.; Karampeazis, A.; Agelaki, S.; Kentepozidis, N.; Polyzos, A.; Kotsa 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 48 KB